URGN

UroGen Pharma Ltd.

16.97 USD
+0.46 (+2.79%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

UroGen Pharma Ltd. stock is up 28.17% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 7 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 5 CALLs, 5 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Jun 18:02 16 Aug, 2024 15.00 CALL 73 393
12 Jun 18:33 16 Aug, 2024 15.00 CALL 295 393
13 Jun 15:28 16 Aug, 2024 15.00 PUT 190 25
13 Jun 15:29 21 Jun, 2024 17.50 PUT 200 0
13 Jun 19:58 16 Aug, 2024 15.00 PUT 150 25
14 Jun 15:07 15 Nov, 2024 15.00 PUT 174 0
14 Jun 19:40 16 Aug, 2024 20.00 CALL 87 77
18 Jun 14:18 19 Jul, 2024 17.50 CALL 200 707
18 Jun 14:20 16 Aug, 2024 17.50 PUT 200 5
24 Jun 17:02 19 Jul, 2024 17.50 CALL 199 869

About UroGen Pharma Ltd.

UroGen Pharma Ltd. engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs. The company's lead product candidate is UGN-102, which is in Phase III clinical trials.

  • Ladenburg Thalmann
    Fri Jun 14, 14:39
    buy
    confirm
  • Oppenheimer
    Fri Jun 14, 10:03
    buy
    confirm
  • HC Wainwright & Co.
    Fri Jun 14, 06:19
    buy
    confirm